Fig. 1: CONSORT diagram of all participants who were assessed for eligibility for the trial, randomized to AV-EXT + TAU, AV-BRF + TAU or TAU alone, and followed up to 28 weeks.
From: Digital AVATAR therapy for distressing voices in psychosis: the phase 2/3 AVATAR2 trial
Follow-up at 16 weeks: 16 weeks after baseline (post-treatment follow-up). Follow-up at 28 weeks: 28 weeks after the baseline.
